ITM researchers published a letter in The Lancet today on “Blood as medicine: social meanings of blood and the success of Ebola trials”.

The authors are part of an interdisciplinary group of researchers of the Ebola-Tx Trial Platform linked to the European Union funded Ebola-Tx trial led by ITM. Preparations for this convalescent plasma trial are ongoing in MSF’s Donka Ebola treatment centre in Conakry, Guinea.